{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:21:59Z","timestamp":1765959719711},"reference-count":36,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.numecd.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T14:36:48Z","timestamp":1372171008000},"page":"10-17","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lower incidence of macrovascular complications in\u00a0patients on insulin glargine versus those on basal human insulins: A population-based cohort study in\u00a0Italy"],"prefix":"10.1016","volume":"24","author":[{"given":"S.","family":"Cammarota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Citarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Manzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Menditto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mezzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Riegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Putignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tragni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Novellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2013.04.002_bib1","series-title":"Disease control priorities in developing countries","article-title":"Diabetes: the pandemic and potential solutions","author":"Narayan","year":"2006"},{"issue":"5","key":"10.1016\/j.numecd.2013.04.002_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.numecd.2009.10.009","article-title":"The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory","volume":"21","author":"Marchesini","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2013.04.002_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1586\/erp.11.78","article-title":"The impact of diabetes mellitus on healthcare costs in Italy","volume":"11","author":"Giorda","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"Suppl. 1","key":"10.1016\/j.numecd.2013.04.002_bib4","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142012 (Position Statement)","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2013.04.002_bib5","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2013.04.002_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJMra040832","article-title":"Insulin analogues","volume":"352","author":"Hirsch","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2013.04.002_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/pds.1741","article-title":"Incidence rates of heart failure, stroke, and acute myocardial infarction among type 2 diabetic patients using insulin glargine and other insulin","volume":"18","author":"Juhaeri","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.numecd.2013.04.002_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.numecd.2010.10.016","article-title":"The burden of hospitalization\u00a0related to diabetes mellitus: a population-based study","volume":"22","author":"De Berardis","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2013.04.002_bib9","first-page":"306","article-title":"Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population","volume":"11","author":"Schultz","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.numecd.2013.04.002_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0895-4356(98)00161-9","article-title":"The use of automated data to identify\u00a0complications and comorbidities of diabetes: a validation study","volume":"52","author":"Newton","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.numecd.2013.04.002_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2840-6-5","article-title":"Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases","volume":"6","author":"Brocco","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2013.04.002_bib12","first-page":"15","article-title":"Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization","volume":"14","author":"Young","year":"2008","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1016\/j.numecd.2013.04.002_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2337\/diacare.24.1.51","article-title":"Potential short-term economic benefits of improved glycemic control: a managed care perspective","volume":"24","author":"Menzin","year":"2001","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.numecd.2013.04.002_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/1055-9965.EPI-10-0817","article-title":"Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark","volume":"20","author":"Bosco","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.numecd.2013.04.002_bib15","doi-asserted-by":"crossref","first-page":"e21368","DOI":"10.1371\/journal.pone.0021368","article-title":"Cancer risk associated with insulin glargine among adult type 2 diabetes patients \u2013 a nationwide cohort study","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.numecd.2013.04.002_bib16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/pds.1821","article-title":"An algorithm to identify incident myocardial infarction using medicaid data","volume":"18","author":"Choma","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.numecd.2013.04.002_bib17","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.numecd.2013.04.002_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jclinepi.2007.07.011","article-title":"The performance of different propensity-score methods for estimating relative risks","volume":"61","author":"Austin","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.numecd.2013.04.002_bib19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"10.1016\/j.numecd.2013.04.002_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1742-1241.2011.02880.x","article-title":"Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain","volume":"66","author":"Delgado","year":"2012","journal-title":"J Clin Pract"},{"issue":"3","key":"10.1016\/j.numecd.2013.04.002_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/193229681100500303","article-title":"Identifying type 1 and type 2 diabetic cases using administrative data: a tree-structured model","volume":"5","author":"Lo-Ciganic","year":"2011","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.numecd.2013.04.002_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1464-5491.2006.01851.x","article-title":"The impact of second-level specialized care on hospitalization in persons with diabetes: a multilevel population-based study","volume":"23","author":"Giorda","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2013.04.002_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UKPDS Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2013.04.002_bib24","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2013.04.002_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a112408","article-title":"Bias due to misclassification in the estimation of relative risk","volume":"105","author":"Copeland","year":"1977","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.numecd.2013.04.002_bib26","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0149-2918(03)80156-X","article-title":"Insulin glargine: a systematic review of a long-acting insulin analogue","volume":"25","author":"Wang","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.numecd.2013.04.002_bib27","doi-asserted-by":"crossref","first-page":"950","DOI":"10.2337\/diacare.28.4.950","article-title":"Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes","volume":"28","author":"Rosenstock","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2013.04.002_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.numecd.2013.04.002_bib29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/bmj.285.6349.1180","article-title":"Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg?","volume":"285","author":"Potter","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.numecd.2013.04.002_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/dia.2006.8.237","article-title":"Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine","volume":"8","author":"Gerich","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.numecd.2013.04.002_bib31","first-page":"571","article-title":"Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs.\u00a0NPH\u00a0basal insulin in subjects with type 1 diabetes","volume":"19","author":"Bolli","year":"2009","journal-title":"Nutr\u00a0Metab\u00a0Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2013.04.002_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.diabres.2006.11.002","article-title":"Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes \u2013 the glargine and aspart study (GLASS) a randomised cross-over study","volume":"77","author":"Chatterjee","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2013.04.002_bib33","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.diabres.2010.09.026","article-title":"Comparison of fasting capillary glucose variability between insulin glargine and NPH","volume":"91","author":"Mu","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2013.04.002_bib34","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.numecd.2013.04.002_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"ORIGIN Trial Investigators","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2013.04.002_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.numecd.2012.10.004","article-title":"Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results","volume":"22","author":"Bolli","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475313000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T08:01:54Z","timestamp":1563264114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475313000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0939475313000902"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2013.04.002","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower incidence of macrovascular complications in\u00a0patients on insulin glargine versus those on basal human insulins: A population-based cohort study in\u00a0Italy","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2013.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}